Sandrine Cammas-Marion

Dr. Sandrine Cammas-Marion

CNRS
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1997 in Journal of Controlled Release
Verified
Journal Article
Closed access
Sandrine Cammas-MarionSandrine Cammas-Marion
Sandrine Cammas-Marion
KSK Suzuki
K Suzuki
CSC Sone
C Sone
YSY Sakurai
Y Sakurai
KKK Kataoka
K Kataoka
TOT Okano
T Okano

1 February 2012 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
ZHZhi Wei Huang
Zhi Wei Huang
VLVéronique Laurent
Véronique Laurent
GCGhizlane Chetouani
Ghizlane Chetouani
JLJulia Y. Ljubimova
Julia Y. Ljubimova
EHEggehard Holler
Eggehard Holler
Sandrine Cammas-MarionSandrine Cammas-Marion
Sandrine Cammas-Marion

1 November 2009 in Recent Advances in Drug Delivery and Formulation
Verified
Journal Article
Closed access
PDF file
TBThierry Benvegnu
Thierry Benvegnu
LLLoïc Lemiègre
Loïc Lemiègre
Sandrine Cammas-MarionSandrine Cammas-Marion
Sandrine Cammas-Marion
Archaeosomes made from natural archaeal membrane lipids and/or synthetic lipid analogues have been extensively studied for potential applications in drug and vaccine delivery over the past decade only. Archaeal-type lipids consist of archaeol (diether) and/or caldarchaeol (tetraether) core structures wherein regularly branched and usually fully saturated phytanyl chains (20-40 carbons in lengths), are attached via ether bonds to the sn-2,3 carbons of the glycerol backbone. Archaeosomes constitute a novel generation of liposomes that exhibit high stabilities to low or high temperatures, acidic or alkaline pH, oxidative conditions, high pressure, action of phospholipases, bile salts and serum proteins. These properties associated with a good safety profile are beneficial for nanotechnological applications in drug and gene delivery. Additionally, archaeosome formulations could be used as efficient carriers of antigens and/or adjuvants promoting antigen-specific, humoral and cell-mediated immune responses, in addition to antigen-specific mucosal immune responses in the vaccinated hosts. The immune responses are well sustained over time, and are subject to strong memory responses. Nanodelivery-based vaccinations using archaeosomes could then represent a promising approach for treating and preventing infections, allergies, and neoplastic or cancer diseases. In this review, the few recent US, World and European patents developing archaeosomes for these biotechnological applications in Health are discussed.

1 June 1999 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
Sandrine Cammas-MarionSandrine Cammas-Marion
Sandrine Cammas-Marion
MBMarie-Maud Béar
Marie-Maud Béar
LMLaurence Moine
Laurence Moine
RERaphaële Escalup
Raphaële Escalup
GPGilles Ponchel
Gilles Ponchel
PGPhilippe Guérin
Philippe Guérin

11 July 2014 in Journal of Drug Targeting
Verified
Journal Article
Closed access
PLPascal Loyer
Pascal Loyer
Sandrine Cammas-MarionSandrine Cammas-Marion
Sandrine Cammas-Marion
The field of specific drug delivery is an expanding research domain. Besides the use of liposomes formed from various lipids, natural and synthetic polymers have been developed to prepare more efficient drug delivery systems either under macromolecular prodrugs or under particulate nanovectors. To ameliorate the biocompatibility of such nanocarriers, degradable natural or synthetic polymers have attracted the interest of many researchers. In this context, poly(malic acid) (PMLA) extracted from microorganisms or synthesized from malic or aspartic acid was used to prepare water-soluble drug carriers or nanoparticles. Within this review, both the preparation and the applications of PMLA derivatives are described emphasizing the in vitro and in vivo assays. The results obtained by several groups highlight the interest of such polyesters in the field of drug delivery.

8 March 2010 in Biotechnology Journal
Verified
Journal Article
Closed access
PDF file
VLVeronique Laurent
Veronique Laurent
AFAurore Fraix
Aurore Fraix
TMTristan Montier
Tristan Montier
Sandrine Cammas-MarionSandrine Cammas-Marion
Sandrine Cammas-Marion
CRCatherine Ribault
Catherine Ribault
PLPascal Loyer
Pascal Loyer